• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Nested PCR-linked capillary electrophoresis and single-strand conformation polymorphisms for detection of macrolide-resistant Mycoplasma pneumoniae in Beijing, China.巢式 PCR-连接毛细管电泳和单链构象多态性检测中国北京地区耐大环内酯类肺炎支原体。
J Clin Microbiol. 2010 Dec;48(12):4567-72. doi: 10.1128/JCM.00400-10. Epub 2010 Sep 22.
2
Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high-resolution melt analysis.通过实时聚合酶链反应和高分辨率熔解分析检测肺炎支原体中的大环内酯类耐药性。
Antimicrob Agents Chemother. 2008 Oct;52(10):3542-9. doi: 10.1128/AAC.00582-08. Epub 2008 Jul 21.
3
Single-nucleotide polymorphism PCR for the detection of Mycoplasma pneumoniae and determination of macrolide resistance in respiratory samples.用于检测呼吸道样本中肺炎支原体及确定大环内酯类耐药性的单核苷酸多态性聚合酶链反应
J Microbiol Methods. 2014 Jul;102:32-6. doi: 10.1016/j.mimet.2014.04.009. Epub 2014 Apr 26.
4
Rapid detection of Mycoplasma pneumoniae and its macrolide-resistance mutation by Cycleave PCR.采用Cycleave PCR 快速检测肺炎支原体及其大环内酯类耐药突变。
Diagn Microbiol Infect Dis. 2014 Apr;78(4):333-7. doi: 10.1016/j.diagmicrobio.2013.12.002. Epub 2013 Dec 13.
5
Development of an endpoint genotyping assay to detect the Mycoplasma pneumoniae 23S rRNA gene and distinguish the existence of macrolide resistance-associated mutations at position 2063.开发一种终点基因分型检测方法,用于检测肺炎支原体23S rRNA基因,并区分2063位大环内酯耐药相关突变的存在情况。
J Microbiol Methods. 2016 Dec;131:130-134. doi: 10.1016/j.mimet.2016.10.017. Epub 2016 Oct 24.
6
Community outbreak of macrolide-resistant Mycoplasma pneumoniae in Yamagata, Japan in 2009.2009 年日本山形县爆发的大环内酯类耐药肺炎支原体社区感染。
Pediatr Infect Dis J. 2013 Mar;32(3):237-40. doi: 10.1097/INF.0b013e31827aa7bd.
7
Macrolide Resistance and MLVA Typing in Children in Beijing, China, in 2016: Is It Relevant?2016 年中国北京儿童大环内酯类耐药与 MLVA 分型:是否相关?
Biomed Environ Sci. 2020 Dec 20;33(12):916-924. doi: 10.3967/bes2020.125.
8
[Survey of macrolide resistance in Mycoplasma pneumoniae in adult patients with community-acquired pneumonia in Beijing, China].[中国北京成年社区获得性肺炎患者肺炎支原体大环内酯类耐药性调查]
Zhonghua Jie He He Hu Xi Za Zhi. 2013 Dec;36(12):954-8.
9
A study of community-acquired in Yantai, China.中国烟台一项关于社区获得性(疾病)的研究。 (原句表述不完整,推测补充完整后大致是这样的意思,因为“A study of community-acquired...”后面缺少具体所研究的关于社区获得性的内容,比如疾病等)
Colomb Med (Cali). 2018 Jun 30;49(2):160-163. doi: 10.25100/cm.v49i2.3813.
10
Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in Germany.德国大环内酯类耐药肺炎支原体株的发生情况。
Clin Microbiol Infect. 2010 Jun;16(6):613-6. doi: 10.1111/j.1469-0691.2009.02968.x. Epub 2009 Sep 17.

引用本文的文献

1
antimicrobial susceptibility of isolates across different regions of China in 2023.2023年中国不同地区分离株的抗菌药物敏感性
JAC Antimicrob Resist. 2025 Jul 30;7(4):dlaf124. doi: 10.1093/jacamr/dlaf124. eCollection 2025 Aug.
2
Atelectasis predicts poor prognosis in pediatric macrolides-unresponsive pneumonia with A2063/2064G mutations treated with azithromycin.肺不张预示着患有A2063/2064G突变且接受阿奇霉素治疗的小儿大环内酯类耐药性肺炎预后不良。
Front Cell Infect Microbiol. 2025 Jun 27;15:1604102. doi: 10.3389/fcimb.2025.1604102. eCollection 2025.
3
Epidemiological, clinical, and genotypic characteristics of pediatric infections: an 8-year survey in Suzhou, China in the pre- and post-COVID-19 eras.儿童感染的流行病学、临床和基因型特征:中国苏州在新冠疫情前后的8年调查
Front Microbiol. 2024 Oct 15;15:1483152. doi: 10.3389/fmicb.2024.1483152. eCollection 2024.
4
Increased macrolide resistance rate of correlated with epidemic in Beijing, China in 2023.2023年,中国北京大环内酯类耐药率上升与疫情相关。
Front Microbiol. 2024 Aug 6;15:1449511. doi: 10.3389/fmicb.2024.1449511. eCollection 2024.
5
Azithromycin Effectiveness in Children with Mutated Pneumonia.阿奇霉素对肺炎突变患儿的疗效
Infect Drug Resist. 2024 Jul 11;17:2933-2942. doi: 10.2147/IDR.S466994. eCollection 2024.
6
Clinical features and risk factors analysis of bronchitis obliterans due to refractory Mycoplasma pneumoniae pneumonia in children: a nomogram prediction model.儿童难治性肺炎支原体肺炎致闭塞性细支气管炎的临床特征及危险因素分析:列线图预测模型。
BMC Infect Dis. 2021 Oct 21;21(1):1085. doi: 10.1186/s12879-021-06783-4.
7
Macrolide Resistance, Clinical Features, and Cytokine Profiles in Taiwanese Children With Infection.台湾感染儿童的大环内酯类耐药性、临床特征及细胞因子谱
Open Forum Infect Dis. 2021 Aug 9;8(9):ofab416. doi: 10.1093/ofid/ofab416. eCollection 2021 Sep.
8
Characteristics and Outcome of Severe Pneumonia Admitted to PICU in Shanghai: A Retrospective Cohort Study.上海儿童重症监护病房收治的重症肺炎的特征与转归:一项回顾性队列研究
Crit Care Explor. 2021 Mar 23;3(3):e0366. doi: 10.1097/CCE.0000000000000366. eCollection 2021 Mar.
9
The Prevalence of in ML-Resistant Isolates to Clarithromycin in Patients with Respiratory Infections.呼吸道感染患者中耐大环内酯类肺炎支原体分离株对克拉霉素的耐药率
Rep Biochem Mol Biol. 2020 Jul;9(2):156-162. doi: 10.29252/rbmb.9.2.156.
10
Allele-specific real-time PCR testing for minor macrolide-resistant Mycoplasma Pneumoniae.针对小剂量大环内酯类耐药肺炎支原体的等位基因特异性实时 PCR 检测。
BMC Infect Dis. 2019 Jul 12;19(1):616. doi: 10.1186/s12879-019-4228-4.

本文引用的文献

1
Emerging macrolide resistance in Mycoplasma pneumoniae in children: detection and characterization of resistant isolates.儿童肺炎支原体新出现的大环内酯类耐药性:耐药菌株的检测与特征分析
Pediatr Infect Dis J. 2009 Aug;28(8):693-6. doi: 10.1097/INF.0b013e31819e3f7a.
2
Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis.通过实时聚合酶链反应和熔解曲线分析直接在临床标本中检测到法国肺炎支原体对大环内酯类药物的耐药性增加。
J Antimicrob Chemother. 2009 Jul;64(1):52-8. doi: 10.1093/jac/dkp160. Epub 2009 May 9.
3
Antimicrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant strains from Shanghai, China.中国上海肺炎支原体分离株的抗菌药敏性及大环内酯类耐药菌株的分子分析
Antimicrob Agents Chemother. 2009 May;53(5):2160-2. doi: 10.1128/AAC.01684-08. Epub 2009 Mar 9.
4
New insights into the pathogenesis and detection of Mycoplasma pneumoniae infections.肺炎支原体感染的发病机制与检测新见解
Future Microbiol. 2008 Dec;3(6):635-48. doi: 10.2217/17460913.3.6.635.
5
Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high-resolution melt analysis.通过实时聚合酶链反应和高分辨率熔解分析检测肺炎支原体中的大环内酯类耐药性。
Antimicrob Agents Chemother. 2008 Oct;52(10):3542-9. doi: 10.1128/AAC.00582-08. Epub 2008 Jul 21.
6
Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia.社区获得性肺炎儿科患者中肺炎支原体对大环内酯类药物耐药性增加。
Antimicrob Agents Chemother. 2008 Jan;52(1):348-50. doi: 10.1128/AAC.00779-07. Epub 2007 Oct 22.
7
First report of macrolide-resistant strains and description of a novel nucleotide sequence variation in the P1 adhesin gene in Mycoplasma pneumoniae clinical strains isolated in France over 12 years.法国12年间分离的肺炎支原体临床菌株中耐大环内酯类菌株的首次报告及P1黏附素基因新核苷酸序列变异的描述
J Clin Microbiol. 2007 Nov;45(11):3534-9. doi: 10.1128/JCM.01345-07. Epub 2007 Sep 19.
8
Evaluation of eight commercial tests for Mycoplasma pneumoniae antibodies in the absence of acute infection.在无急性感染情况下对八种肺炎支原体抗体商业检测方法的评估。
Clin Microbiol Infect. 2006 Jul;12(7):685-8. doi: 10.1111/j.1469-0691.2006.01469.x.
9
Species-specific antibiotic-ribosome interactions: implications for drug development.物种特异性抗生素-核糖体相互作用:对药物开发的影响。
Biol Chem. 2005 Dec;386(12):1239-52. doi: 10.1515/BC.2005.141.
10
Mechanisms of drug resistance in Mycoplasma pneumoniae.肺炎支原体的耐药机制
Curr Drug Targets Infect Disord. 2005 Sep;5(3):263-71. doi: 10.2174/1568005054880109.

巢式 PCR-连接毛细管电泳和单链构象多态性检测中国北京地区耐大环内酯类肺炎支原体。

Nested PCR-linked capillary electrophoresis and single-strand conformation polymorphisms for detection of macrolide-resistant Mycoplasma pneumoniae in Beijing, China.

机构信息

Beijing Center for Disease Prevention and Control, Department of Bacteriology, Capital Institute of Pediatrics, No. 2 Yabao Road, Beijing 100020, People's Republic of China.

出版信息

J Clin Microbiol. 2010 Dec;48(12):4567-72. doi: 10.1128/JCM.00400-10. Epub 2010 Sep 22.

DOI:10.1128/JCM.00400-10
PMID:20861333
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3008430/
Abstract

Mycoplasma pneumoniae is usually susceptible to macrolides, but macrolide-resistant strains have been found frequently in recent years. Mutations in domain V of the 23S rRNA gene of M. pneumoniae interfere with the binding of macrolides to rRNA and mediate macrolide resistance. In this study, we developed a rapid and inexpensive method that combines nested PCR (nPCR), single-strand conformation polymorphisms (SSCPs), and capillary electrophoresis (CE) to detect macrolide-resistant mutants directly from throat swabs. nPCR was used to specifically amplify M. pneumoniae 23S rRNA gene fragments containing mutations, and amplicons were analyzed by CE-SSCP for macrolide resistance mutations, with results confirmed by sequencing. From January to December 2009, 665 throat swabs were collected in Beijing, China, yielding 110 samples that tested positive for M. pneumoniae by nPCR and serological testing. We randomly selected 64 positive throat swabs for CE-SSCP analysis. The A2063G mutation was found in 57 samples, and a coexisting T2611C mutation was identified in 1 sample. An A2063T mutation was identified in 1 sample. The total mutation rate was 91%. All mutant samples identified by nPCR-CE-SSCP were sequenced. The nPCR-CE-SSCP method could identify macrolide-resistant mutants directly from clinical samples. This is the first report of an nPCR-CE-SSCP assay for the detection of dominant mutations that confer macrolide resistance on M. pneumoniae. This approach would allow clinicians to choose appropriate therapy rapidly and could be used as a screening method for genetic mutations related to antibiotic resistance.

摘要

肺炎支原体通常对大环内酯类药物敏感,但近年来已发现大量大环内酯类耐药菌株。肺炎支原体 23S rRNA 基因结构域 V 的突变会干扰大环内酯类药物与 rRNA 的结合,并介导大环内酯类耐药。本研究建立了一种快速、经济的方法,结合巢式 PCR(nPCR)、单链构象多态性(SSCP)和毛细管电泳(CE),可直接从咽拭子中检测大环内酯类耐药突变体。nPCR 用于特异性扩增包含突变的肺炎支原体 23S rRNA 基因片段,并用 CE-SSCP 分析对大环内酯类耐药突变,测序结果进行确认。2009 年 1 月至 12 月,在中国北京采集了 665 份咽拭子,其中 110 份经 nPCR 和血清学检测为肺炎支原体阳性。我们随机选择了 64 份阳性咽拭子进行 CE-SSCP 分析。在 57 份样本中发现了 A2063G 突变,在 1 份样本中发现了同时存在的 T2611C 突变,在 1 份样本中发现了 A2063T 突变。总突变率为 91%。所有经 nPCR-CE-SSCP 鉴定的突变样本均进行了测序。nPCR-CE-SSCP 方法可直接从临床样本中鉴定大环内酯类耐药突变体。这是首次报道用于检测导致肺炎支原体大环内酯类耐药的优势突变的 nPCR-CE-SSCP 检测方法。该方法可使临床医生快速选择合适的治疗方法,也可用作与抗生素耐药相关的基因突变的筛查方法。